Skip to main content

Resource Library

Webinar icon

July 16, 2020

Methamphetamine Use Disorders: Considerations From Across the Sequential Intercept Model (SIM)

While much focus and funding has been devoted to combating the opioid epidemic, many communities have begun or continued to grapple with the impacts of methamphetamine use disorders. Unlike opioid use disorders, there are no medications approved by the U.S. Food and Drug Administration for the treatment of methamphetamine use disorders, and these disorders have historically been addressed through criminal justice responses. However, as many criminal justice professionals learn about the science of addiction and changes in the brain that result from substance misuse, there is growing interest in addressing issues related to methamphetamines using a public health approach. This webinar presents an overview of methamphetamine use and justice involvement and also explores emerging or promising practices to address the needs of individuals with methamphetamine use disorders who interface with the justice system.


  • Richard Rawson, Ph.D., Emeritus Professor, University of California at Los Angeles
  • Jan Tokumoto, Spokane Police Department co-responder team, Washington (Intercepts 0–1)
  • Sergeant Jay Kernkamp, Spokane Police Department, Washington
  • Sheena Hargrave, M.Ed, SUDP, Spokane Police Department co-responder team, Washington
  • Ron Bailey, Director, 12th Judicial District Drug Court, Tennessee (Intercept 3)

To view a PDF version of the slide deck that was used during this presentation, click here.

How would you rate this?

Thank you for submitting your feedback.

Pick Your Pathway Pathway